Dexcom, the local maker of continuous glucose monitors, received a warning letter from the Food and Drug Administration last week citing issues at two of its manufacturing facilities.

(Reuters) -Medical device maker Dexcom (NASDAQ:DXCM) said it has received a warning letter from the U.S. Food and Drug Administration following inspections of its two key manufacturing facilities ...